Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 51
Filtrar
3.
Rev Panam Salud Publica ; 47: e17, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36909805

RESUMO

The Faculty of Health Sciences at the Universitat Oberta de Catalunya (Barcelona, Spain) was officially designated a 'World Health Organization (WHO) Collaborating Centre in eHealth' on 5 April 2018. The Centre aims to provide support to countries willing to develop new telemedicine services; to promote the use of eHealth; and to study the adoption and use of mobile health in countries of both the Region of the Americas and Europe. On 11 March 2020, WHO declared COVID-19 a global pandemic given the significant increase in the number of cases worldwide. Since then, the Centre has played an important role in addressing COVID-19 by undertaking fruitful cooperative activities. Lockdowns and social distancing in response to the high contagion rate of COVID-19 were the main triggers for a challenging digital transformation in many sectors, especially in healthcare. In this extreme crisis scenario, the rapid adoption of digital health solutions and technological tools was key to responding to the enormous pressure on healthcare systems. Telemedicine has become a necessary component of clinical practice for the purpose of providing safer patient care, and it has been used to support the healthcare needs of COVID-19 patients and routine primary care patients alike. This article describes the Centre's contribution to the work of the Pan American Health Organization (PAHO) and WHO in supporting Latin American and European countries to develop new telemedicine services and guidance on how to address COVID-19 through digital health solutions. Future actions are also highlighted.


La Facultad de Ciencias de la Salud de la Universitat Oberta de Catalunya (Barcelona, España) fue oficialmente designada centro colaborador de la Organización Mundial de la Salud (OMS) en el ámbito de la salud digital (también denominada "cibersalud" o "eSalud") el 5 de abril del 2018. El centro está destinado a prestar apoyo a los países que deseen crear nuevos servicios de telemedicina, promover el uso de la salud digital, y estudiar la adopción y el uso de la salud móvil en países de la Región de las Américas y Europa. El 11 de marzo del 2020 la OMS declaró la COVID-19 una pandemia mundial dado el aumento significativo del número de casos en todo el mundo. Desde entonces, el centro ha desempeñado un papel importante en la respuesta a la COVID-19 mediante la realización de fructíferas actividades de cooperación. Los confinamientos y el distanciamiento social en respuesta a la alta tasa de contagio de la COVID­19 fueron los principales desencadenantes de una compleja transformación digital en muchos sectores, especialmente en la atención de salud. En esta situación de crisis extrema, la rápida adopción de soluciones digitales y herramientas tecnológicas fue clave para dar respuesta a la enorme presión sobre los sistemas de salud. La telemedicina se ha convertido en un componente necesario de la práctica clínica con el fin de proporcionar una atención más segura a los pacientes, y se ha empleado para apoyar las necesidades de atención de salud de los pacientes con COVID-19 así como los pacientes habituales de los servicios de atención primaria. En este artículo se describe la contribución del centro a la labor de la Organización Panamericana de la Salud (OPS) y la OMS al prestar apoyo a los países de América Latina y Europa en la creación de nuevos servicios de telemedicina y brindar orientación sobre cómo abordar la COVID-19 con soluciones digitales de salud. También se destacan las acciones futuras.


A Faculdade de Ciências da Saúde da Universitat Oberta de Catalunya (Barcelona, Espanha) foi oficialmente designada, em 5 de abril de 2018, "Centro Colaborador da Organização Mundial da Saúde (OMS) em eSaúde". O centro tem como objetivo prestar apoio aos países dispostos a desenvolver novos serviços de telemedicina; promover o uso da eSaúde, ou saúde digital; e estudar a adoção e o uso da saúde móvel em países da Região das Américas e da Europa. Em 11 de março de 2020, a OMS declarou a COVID-19 como pandemia global, dado o aumento significativo do número de casos no mundo inteiro. Desde então, o centro tem desempenhado um papel importante no enfrentamento da COVID-19, empreendendo atividades frutíferas de cooperação. Os lockdowns e o distanciamento social em resposta à alta taxa de contágio da COVID-19 foram os principais desencadeadores de uma transformação digital desafiadora em muitos setores, especialmente na área da saúde. Neste cenário de crise extrema, a rápida adoção de soluções digitais de saúde e ferramentas tecnológicas foi fundamental para responder à enorme pressão sobre os sistemas de saúde. A telemedicina se tornou um componente necessário da prática clínica, com o objetivo de oferecer um atendimento mais seguro aos pacientes, e tem sido usada para apoiar as necessidades de saúde tanto dos pacientes com COVID-19 como dos pacientes da atenção primária de rotina. Este artigo descreve a contribuição do centro para o trabalho da Organização Pan-Americana da Saúde (OPAS) e da OMS no apoio aos países latino-americanos e europeus para desenvolver novos serviços de telemedicina e orientação sobre como enfrentar a COVID-19 por meio de soluções de saúde digitais. Ações futuras também são destacadas.

4.
Rev Panam Salud Publica ; 47, 2023. Centros Colaboradores de la OPS/OMS
Artigo em Inglês | PAHO-IRIS | ID: phr-57143

RESUMO

[ABSTRACT]. The Faculty of Health Sciences at the Universitat Oberta de Catalunya (Barcelona, Spain) was officially desig- nated a ‘World Health Organization (WHO) Collaborating Centre in eHealth’ on 5 April 2018. The Centre aims to provide support to countries willing to develop new telemedicine services; to promote the use of eHealth; and to study the adoption and use of mobile health in countries of both the Region of the Americas and Europe. On 11 March 2020, WHO declared COVID-19 a global pandemic given the significant increase in the number of cases worldwide. Since then, the Centre has played an important role in addressing COVID-19 by undertaking fruitful cooperative activities. Lockdowns and social distancing in response to the high contagion rate of COVID-19 were the main triggers for a challenging digital transformation in many sectors, especially in healthcare. In this extreme crisis scenario, the rapid adoption of digital health solutions and technological tools was key to responding to the enormous pressure on healthcare systems. Telemedicine has become a necessary component of clinical practice for the purpose of providing safer patient care, and it has been used to support the healthcare needs of COVID-19 patients and routine primary care patients alike. This article describes the Centre’s contribution to the work of the Pan American Health Organization (PAHO) and WHO in supporting Latin American and European countries to develop new telemedicine services and guidance on how to address COVID-19 through digital health solutions. Future actions are also highlighted.


[RESUMEN]. La Facultad de Ciencias de la Salud de la Universitat Oberta de Catalunya (Barcelona, España) fue ofi- cialmente designada centro colaborador de la Organización Mundial de la Salud (OMS) en el ámbito de la salud digital (también denominada “cibersalud” o “eSalud”) el 5 de abril del 2018. El centro está destinado a prestar apoyo a los países que deseen crear nuevos servicios de telemedicina, promover el uso de la salud digital, y estudiar la adopción y el uso de la salud móvil en países de la Región de las Américas y Europa. El 11 de marzo del 2020 la OMS declaró la COVID-19 una pandemia mundial dado el aumento significativo del número de casos en todo el mundo. Desde entonces, el centro ha desempeñado un papel importante en la respuesta a la COVID-19 mediante la realización de fructíferas actividades de cooperación. Los confinamien- tos y el distanciamiento social en respuesta a la alta tasa de contagio de la COVID–19 fueron los principales desencadenantes de una compleja transformación digital en muchos sectores, especialmente en la atención de salud. En esta situación de crisis extrema, la rápida adopción de soluciones digitales y herramientas tec- nológicas fue clave para dar respuesta a la enorme presión sobre los sistemas de salud. La telemedicina se ha convertido en un componente necesario de la práctica clínica con el fin de proporcionar una atención más segura a los pacientes, y se ha empleado para apoyar las necesidades de atención de salud de los pacientes con COVID-19 así como los pacientes habituales de los servicios de atención primaria. En este artículo se describe la contribución del centro a la labor de la Organización Panamericana de la Salud (OPS) y la OMS al prestar apoyo a los países de América Latina y Europa en la creación de nuevos servicios de telemedicina y brindar orientación sobre cómo abordar la COVID-19 con soluciones digitales de salud. También se destacan las acciones futuras.


[RESUMO]. A Faculdade de Ciências da Saúde da Universitat Oberta de Catalunya (Barcelona, Espanha) foi oficial- mente designada, em 5 de abril de 2018, “Centro Colaborador da Organização Mundial da Saúde (OMS) em eSaúde”. O centro tem como objetivo prestar apoio aos países dispostos a desenvolver novos serviços de telemedicina; promover o uso da eSaúde, ou saúde digital; e estudar a adoção e o uso da saúde móvel em países da Região das Américas e da Europa. Em 11 de março de 2020, a OMS declarou a COVID-19 como pandemia global, dado o aumento significativo do número de casos no mundo inteiro. Desde então, o centro tem desempenhado um papel importante no enfrentamento da COVID-19, empreendendo atividades frutíferas de cooperação. Os lockdowns e o distanciamento social em resposta à alta taxa de contágio da COVID-19 foram os principais desencadeadores de uma transformação digital desafiadora em muitos seto- res, especialmente na área da saúde. Neste cenário de crise extrema, a rápida adoção de soluções digitais de saúde e ferramentas tecnológicas foi fundamental para responder à enorme pressão sobre os sistemas de saúde. A telemedicina se tornou um componente necessário da prática clínica, com o objetivo de oferecer um atendimento mais seguro aos pacientes, e tem sido usada para apoiar as necessidades de saúde tanto dos pacientes com COVID-19 como dos pacientes da atenção primária de rotina. Este artigo descreve a con- tribuição do centro para o trabalho da Organização Pan-Americana da Saúde (OPAS) e da OMS no apoio aos países latino-americanos e europeus para desenvolver novos serviços de telemedicina e orientação sobre como enfrentar a COVID-19 por meio de soluções de saúde digitais. Ações futuras também são destacadas.


Assuntos
COVID-19 , Telemedicina , Estratégias de eSaúde , América Latina , Telemedicina , Estratégias de eSaúde , América Latina , Estratégias de eSaúde
5.
Artigo em Inglês | MEDLINE | ID: mdl-36833860

RESUMO

The financial burden of burn injuries has a considerable impact on patients and healthcare systems. Information and Communication Technologies (ICTs) have demonstrated their utility in the improvement of clinical practice and healthcare systems. Because referral centres for burn injuries cover large geographic areas, many specialists must find new strategies, including telehealth tools for patient evaluation, teleconsultation, and remote monitoring. This systematic review was performed according to PRISMA guidelines. PubMed, Cochrane, Medline, IBECS, and LILACS were the search engines used. Systematic reviews, meta-analyses, clinical trials, and observational studies were included in the study search. The protocol was registered in PROSPERO with the number CRD42022361137. In total, 37 of 185 studies queried for this study were eligible for the systematic review. Thirty studies were comparative observational studies, six were systematic reviews, and one was a randomised clinical trial. Studies suggest that telehealth allows better perception of triage, more accurate estimation of the TBSA, and resuscitation measures in the management of acute burns. In addition, some studies assess that TH tools are equivalent to face-to-face outpatient visits and cost-efficient because of transport savings and unnecessary referrals. However, more studies are required to provide significant evidence. However, the implementation of telehealth should be specifically adapted to each territory.


Assuntos
Queimaduras , Consulta Remota , Telemedicina , Humanos , Telemedicina/métodos , Atenção à Saúde , Triagem , Ensaios Clínicos Controlados Aleatórios como Assunto
6.
Rev. panam. salud pública ; 47: e17, 2023. tab
Artigo em Inglês | LILACS | ID: biblio-1424260

RESUMO

ABSTRACT The Faculty of Health Sciences at the Universitat Oberta de Catalunya (Barcelona, Spain) was officially designated a 'World Health Organization (WHO) Collaborating Centre in eHealth' on 5 April 2018. The Centre aims to provide support to countries willing to develop new telemedicine services; to promote the use of eHealth; and to study the adoption and use of mobile health in countries of both the Region of the Americas and Europe. On 11 March 2020, WHO declared COVID-19 a global pandemic given the significant increase in the number of cases worldwide. Since then, the Centre has played an important role in addressing COVID-19 by undertaking fruitful cooperative activities. Lockdowns and social distancing in response to the high contagion rate of COVID-19 were the main triggers for a challenging digital transformation in many sectors, especially in healthcare. In this extreme crisis scenario, the rapid adoption of digital health solutions and technological tools was key to responding to the enormous pressure on healthcare systems. Telemedicine has become a necessary component of clinical practice for the purpose of providing safer patient care, and it has been used to support the healthcare needs of COVID-19 patients and routine primary care patients alike. This article describes the Centre's contribution to the work of the Pan American Health Organization (PAHO) and WHO in supporting Latin American and European countries to develop new telemedicine services and guidance on how to address COVID-19 through digital health solutions. Future actions are also highlighted.


RESUMEN La Facultad de Ciencias de la Salud de la Universitat Oberta de Catalunya (Barcelona, España) fue oficialmente designada centro colaborador de la Organización Mundial de la Salud (OMS) en el ámbito de la salud digital (también denominada "cibersalud" o "eSalud") el 5 de abril del 2018. El centro está destinado a prestar apoyo a los países que deseen crear nuevos servicios de telemedicina, promover el uso de la salud digital, y estudiar la adopción y el uso de la salud móvil en países de la Región de las Américas y Europa. El 11 de marzo del 2020 la OMS declaró la COVID-19 una pandemia mundial dado el aumento significativo del número de casos en todo el mundo. Desde entonces, el centro ha desempeñado un papel importante en la respuesta a la COVID-19 mediante la realización de fructíferas actividades de cooperación. Los confinamientos y el distanciamiento social en respuesta a la alta tasa de contagio de la COVID-19 fueron los principales desencadenantes de una compleja transformación digital en muchos sectores, especialmente en la atención de salud. En esta situación de crisis extrema, la rápida adopción de soluciones digitales y herramientas tecnológicas fue clave para dar respuesta a la enorme presión sobre los sistemas de salud. La telemedicina se ha convertido en un componente necesario de la práctica clínica con el fin de proporcionar una atención más segura a los pacientes, y se ha empleado para apoyar las necesidades de atención de salud de los pacientes con COVID-19 así como los pacientes habituales de los servicios de atención primaria. En este artículo se describe la contribución del centro a la labor de la Organización Panamericana de la Salud (OPS) y la OMS al prestar apoyo a los países de América Latina y Europa en la creación de nuevos servicios de telemedicina y brindar orientación sobre cómo abordar la COVID-19 con soluciones digitales de salud. También se destacan las acciones futuras.


RESUMO A Faculdade de Ciências da Saúde da Universitat Oberta de Catalunya (Barcelona, Espanha) foi oficialmente designada, em 5 de abril de 2018, "Centro Colaborador da Organização Mundial da Saúde (OMS) em eSaúde". O centro tem como objetivo prestar apoio aos países dispostos a desenvolver novos serviços de telemedicina; promover o uso da eSaúde, ou saúde digital; e estudar a adoção e o uso da saúde móvel em países da Região das Américas e da Europa. Em 11 de março de 2020, a OMS declarou a COVID-19 como pandemia global, dado o aumento significativo do número de casos no mundo inteiro. Desde então, o centro tem desempenhado um papel importante no enfrentamento da COVID-19, empreendendo atividades frutíferas de cooperação. Os lockdowns e o distanciamento social em resposta à alta taxa de contágio da COVID-19 foram os principais desencadeadores de uma transformação digital desafiadora em muitos setores, especialmente na área da saúde. Neste cenário de crise extrema, a rápida adoção de soluções digitais de saúde e ferramentas tecnológicas foi fundamental para responder à enorme pressão sobre os sistemas de saúde. A telemedicina se tornou um componente necessário da prática clínica, com o objetivo de oferecer um atendimento mais seguro aos pacientes, e tem sido usada para apoiar as necessidades de saúde tanto dos pacientes com COVID-19 como dos pacientes da atenção primária de rotina. Este artigo descreve a contribuição do centro para o trabalho da Organização Pan-Americana da Saúde (OPAS) e da OMS no apoio aos países latino-americanos e europeus para desenvolver novos serviços de telemedicina e orientação sobre como enfrentar a COVID-19 por meio de soluções de saúde digitais. Ações futuras também são destacadas.


Assuntos
Humanos , Telemedicina/métodos , Estratégias de eSaúde , COVID-19/terapia , Promoção da Saúde/métodos , Organização Pan-Americana da Saúde , Congressos como Assunto , América Latina
7.
PLoS One ; 17(12): e0277899, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36454968

RESUMO

BACKGROUND: This study attempts to provide a picture of the hesitancy to vaccination against COVID-19 in Spain during the 2021 spring-autumn vaccination campaign, both in the general population and in healthcare professionals. METHODS: The participants were recruited using social media such as Facebook and Twitter, in addition to the cooperation of health personnel contacted with the collaboration of medical scientific societies. A cross-sectional study was carried out that included the response of an online questionnaire. The data were collected from April 30 to September 26, 2021. To assess the different associations between variables to be measured, we fit Poisson regression models with robust variance. RESULTS: Responses were obtained from 3,850 adults from the general population group and 502 health professionals. Of the overall sample, 48.6% of participants from the general population were vaccinated against COVID-19, whereas in the healthcare professionals, 94.8% were vaccinated. The prevalence of general population vaccination increased with age, and was higher in women than men. Most participants did not show a preference for any vaccine itself. However, the prevalence of people vaccinated with their preferred vaccine was higher for the ones vaccinated with Pfizer's vaccine. 6.5% of the general population reported being reticent to be vaccinated. People from younger age groups, people with lower educational levels and those who were not from a risk group showed greater reluctance to be vaccinated. No gender differences in reluctancy were found. CONCLUSIONS: Health professionals were significantly less likely to refuse vaccination even though they had more doubts about the safety and efficacy of vaccines. On the other hand, younger people, those with a lower level of education and those who were not from a risk group were the most hesitant.


Assuntos
COVID-19 , Coronavirus , Adulto , Masculino , Humanos , Feminino , Espanha/epidemiologia , Grupos Populacionais , Vacinas contra COVID-19 , COVID-19/epidemiologia , COVID-19/prevenção & controle , Estudos Transversais , Vacinação , Pessoal de Saúde , Atenção à Saúde
8.
J Med Internet Res ; 24(12): e42397, 2022 12 09.
Artigo em Inglês | MEDLINE | ID: mdl-36485027

RESUMO

BACKGROUND: Digital strategies are innovative approaches to the prevention of skin cancer, but the attrition following this kind of intervention needs to be analyzed. OBJECTIVE: The aim of this paper is to assess the dropouts from studies focused on digital strategies for the prevention of skin cancer. METHODS: We conducted this systematic review with meta-analyses and metaregression according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statements. Search terms for skin cancer, digital strategies, and prevention were combined to search PubMed, Scopus, Web of Science, CINAHL, and Cochrane Library from inception until July 2022. Randomized clinical trials that reported dropouts of participants and compared digital strategies with other interventions to prevent skin cancer in healthy or disease-free participants were included. Two independent reviewers extracted data for analysis. The Revised Cochrane Collaboration Bias tool was employed. We calculated the pooled dropout rate of participants through a meta-analysis of proportions and examined whether dropout was more or less frequent in digital interventions against comparators via an odds ratio (OR) meta-analysis. Data were pooled using a random-effects model. Subgroup meta-analyses were conducted in a meta-analysis of proportions and OR meta-analysis to assess the dropout events when data were sorted by digital interventions or control comparator. A univariate metaregression based on a random-effects model assessed possible moderators of dropout. Participants' dropout rates as pooled proportions were calculated for all groups combined, and the digital and comparator groups separately. OR>1 indicated higher dropouts for digital-based interventions. Metaregressions were performed for age, sex, length of intervention, and sample size. RESULTS: A total of 17 studies were included. The overall pooled dropout rate was 9.5% (95% CI 5.0-17.5). The subgroup meta-analysis of proportions revealed a dropout rate of 11.6% for digital strategies (95% CI 6.8-19.0) and 10.0% for comparators (95% CI 5.5-17.7). A trend of higher dropout rates for digital strategies was observed in the overall (OR 1.16, 95% CI 0.98-1.36) and subgroup OR meta-analysis, but no significant differences were found between the groups. None of the covariates moderated the effect size in the univariate metaregression. CONCLUSIONS: Digital strategies had a higher dropout rate compared to other prevention interventions, but the difference was not significant. Standardization is needed regarding reporting the number of and reasons for dropouts. TRIAL REGISTRATION: International Prospective Register of Systematic Reviews (PROSPERO) CRD42022329669; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=329669.


Assuntos
Neoplasias Cutâneas , Humanos , Viés , Neoplasias Cutâneas/prevenção & controle , Ensaios Clínicos Controlados Aleatórios como Assunto
9.
J Med Internet Res ; 24(11): e38347, 2022 11 30.
Artigo em Inglês | MEDLINE | ID: mdl-36449330

RESUMO

BACKGROUND: Despite Catalonia being an advanced region in terms of digital health adoption, the "Forum for Professional Dialogue" identified the need to improve information and communication technology (ICT) competences as one of the present and future challenges for health care professionals (HPs). OBJECTIVE: We aimed to validate the digital competence test developed ad hoc for this study and to measure the digital competence level of Catalan HPs to establish their current level as the baseline for designing a strategic training plan. METHODS: An exploratory observational study was conducted based on a voluntary survey where sociodemographic, professional and digital tool knowledge, digital tool use, and training needs data were collected and based on the score obtained from a digital competence test developed ad hoc. The digital competence test consisted of 2 "real-life scenarios" with 7 and 11 questions. RESULTS: In total, 803 HPs, of whom 612 (76.2%) were women, completed the survey between June 28 and July 16, 2021. Most participants self-rated their digital competence level as either intermediate (384/803, 47.8%) or basic (357/803, 44.5%). The mean score in the digital competence test was 22.6 (SD 4.3). Therefore, most participants displayed a basic level of digital competence. The internal consistency of the digital competence test was 0.66, and the discrimination index of all questions was ≥0.2 for all items except for 1 question. CONCLUSIONS: This exploratory study highlights the need to improve the digital competence of HPs working in Catalonia, with special effort being made to provide training according to the specific needs of the different HP profiles. The results have informed the Health Plan for Catalonia 2021-2025 and lay the foundations for the development and deployment of a framework program for the digital competences of HPs. The developed digital competence test shows acceptable consistency for the objective pursued, although improvements are needed to fine-tune its accuracy.


Assuntos
Pessoal de Saúde , Tecnologia da Informação , Feminino , Humanos , Masculino , Comunicação , Planejamento em Saúde , Conhecimento
10.
J Med Internet Res ; 24(10): e40877, 2022 10 27.
Artigo em Inglês | MEDLINE | ID: mdl-36301602

RESUMO

BACKGROUND: Several systematic reviews evaluating the use of telemedicine by clinicians, patients, and health authorities to improve the delivery of care in the 53 member states of the World Health Organization (WHO) European Region have been conducted in recent years. However, a study summarizing the findings of these reviews has not been conducted. OBJECTIVE: This overview of systematic reviews aimed to summarize findings regarding the use of telemedicine across the 53 member states and identify the medical fields and levels of care in and at which the effectiveness, feasibility, and applicability of telemedicine have been demonstrated. The barriers to and facilitators of telemedicine use were also evaluated and collated to help with the design and implementation of telemedicine interventions. METHODS: Through a comprehensive systematic evaluation of the published and unpublished literature, we extracted clinical, epidemiological, and technology-related data from each review included in the study. We focused on evaluating the barriers to and facilitators of the use of telemedicine apps across the 53 member states considered. We rated the methodological quality of each of the included reviews based on A Measurement Tool to Assess Systematic Review 2 approach and judged the overall certainty of evidence by using the Grading of Recommendations, Assessment, Development, and Evaluations methodology. The entire process was performed by 2 independent authors. RESULTS: This overview drew on data from >2239 primary studies, with >20,000 enrolled patients in total, within the WHO European Region. On the basis of data from randomized trials, observational studies, and economic evaluations from several countries, the results show a clear benefit of telemedicine technologies in the screening, diagnosis, management, treatment, and long-term follow-up of a series of chronic diseases. However, we were unable to pool the results into a reliable numeric parameter because of the high heterogeneity of intervention methodologies, scheduling, primary study design discrepancies, settings, and geographical locations. In addition to the clinical outcomes of the interventions, the social and economic outcomes are highlighted. CONCLUSIONS: The application of telemedicine is well established across countries in the WHO European Region; however, some countries could still benefit from the many uses of these digital solutions. Barriers related to users, technology, and infrastructure were the largest. Conversely, the provision of health services using technological devices was found to significantly enhance patients' clinical outcomes, improve the long-term follow-up of patients by medical professionals, and offer logistical benefits for both patients and health workers. TRIAL REGISTRATION: PROSPERO (International Prospective Register of Systematic Reviews) CRD42022309375; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=309375.


Assuntos
Telemedicina , Humanos , Revisões Sistemáticas como Assunto , Telemedicina/métodos , Atenção à Saúde , Organização Mundial da Saúde , Tecnologia
11.
Artigo em Inglês | MEDLINE | ID: mdl-35564781

RESUMO

BACKGROUND: Digital health interventions and mobile technologies can help to reduce the rates of obesity and overweight conditions. Although weight management apps are widely used, they usually lack professional content and evaluation, so the quality of these apps cannot be guaranteed. The EVALAPPS project aims to design and validate a tool to assess the safety and effectiveness of health-related apps whose main goal is to manage and prevent obesity and overweight conditions. OBJECTIVE: The aim of this paper is two-fold: (a) to co-create and codesign the EVALAPPS assessment tool and (b) to pilot its feasibility among overweight and obese individuals that use weight control apps. METHODS: A mixed-methods approach was used. A multidisciplinary team (n = 12) participated in a co-creation workshop to provide proposals and inputs about the look and feel of the content, usability aspects, appearance, sections, and main features of the EVALAPPS tool. The tool was tested for its feasibility among 31 overweight and obese individuals, attending the CP Endocrinologia i Nutrició SL Clinic for the first time. Participants were asked to use a specific weight control app [Yazio (YAZIO GmbH, Erfurt, Germany), My FitnessPal (MyFitnessPal, Austin, TX, USA) or MyPlate (MyPlate, Santa Monica, CA, USA)] for two weeks and then evaluate them by using the EVALAPPS (EVALAPPS, David Ganyan, Barcelona, Spain) (June 2020, David Ganyan, Barcelona, Spain) tool. Seven participants were phone interviewed to gain more insight into the use of the EVALAPPS tool. RESULTS: The co-creation workshop allowed conceptualizing the EVALAPPS tool. The feasibility study showed that all criteria from the Usability and Functionality dimensions had valid answers, while Reliability, Security, Privacy, and Health indicators were the dimensions with less valid answers. In all three apps, the dimension with the highest score was Usability/functionality, followed by app purpose. Clinical effectiveness and Development were the dimensions with the lowest scores in all three tested weight control apps. CONCLUSIONS: The participation of the multidisciplinary team and end-users in the conceptualization and testing of a tool to assess health apps was feasible and relevant for the usability of the tool.


Assuntos
Aplicativos Móveis , Sobrepeso , Estudos de Viabilidade , Humanos , Obesidade/prevenção & controle , Reprodutibilidade dos Testes
12.
Artigo em Inglês | MEDLINE | ID: mdl-34886244

RESUMO

(1) Background: The goal of the paper was to establish the factors that influence how people feel about having a medical operation performed on them by a robot. (2) Methods: Data were obtained from a 2017 Flash Eurobarometer (number 460) of the European Commission with 27,901 citizens aged 15 years and over in the 28 countries of the European Union. Logistic regression (odds ratios, OR) to model the predictors of trust in robot-assisted surgery was calculated through motivational factors, using experience and sociodemographic independent variables. (3) Results: The results obtained indicate that, as the experience of using robots increases, the predictive coefficients related to information, attitude, and perception of robots become more negative. Furthermore, sociodemographic variables played an important predictive role. The effect of experience on trust in robots for surgical interventions was greater among men, people between 40 and 54 years old, and those with higher educational levels. (4) Conclusions: The results show that trust in robots goes beyond rational decision-making, since the final decision about whether it should be a robot that performs a complex procedure like a surgical intervention depends almost exclusively on the patient's wishes.


Assuntos
Procedimentos Cirúrgicos Robóticos , Robótica , Adulto , Atitude , Europa (Continente) , Humanos , Masculino , Pessoa de Meia-Idade , Confiança
13.
Front Digit Health ; 3: 707902, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34713179

RESUMO

Background: In order to prevent spread and improve control of infectious diseases, public health experts need to closely monitor human and animal populations. Infectious disease surveillance is an established, routine data collection process essential for early warning, rapid response, and disease control. The quantity of data potentially useful for early warning and surveillance has increased exponentially due to social media and other big data streams. Digital epidemiology is a novel discipline that includes harvesting, analysing, and interpreting data that were not initially collected for healthcare needs to enhance traditional surveillance. During the current COVID-19 pandemic, the importance of digital epidemiology complementing traditional public health approaches has been highlighted. Objective: The aim of this paper is to provide a comprehensive overview for the application of data and digital solutions to support surveillance strategies and draw implications for surveillance in the context of the COVID-19 pandemic and beyond. Methods: A search was conducted in PubMed databases. Articles published between January 2005 and May 2020 on the use of digital solutions to support surveillance strategies in pandemic settings and health emergencies were evaluated. Results: In this paper, we provide a comprehensive overview of digital epidemiology, available data sources, and components of 21st-century digital surveillance, early warning and response, outbreak management and control, and digital interventions. Conclusions: Our main purpose was to highlight the plausible use of new surveillance strategies, with implications for the COVID-19 pandemic strategies and then to identify opportunities and challenges for the successful development and implementation of digital solutions during non-emergency times of routine surveillance, with readiness for early-warning and response for future pandemics. The enhancement of traditional surveillance systems with novel digital surveillance methods opens a direction for the most effective framework for preparedness and response to future pandemics.

14.
Artigo em Espanhol | PAHO-IRIS | ID: phr-54981

RESUMO

[RESUMEN]. Con millones de personas en el mundo en situación de distanciamiento físico por el COVID-19, las tecnologías de la información y comunicaciones (TICs) se han posicionado como uno de los medios principales de interacción y colaboración. Ya al inicio de este milenio se empezaban a mencionar las siguientes ventajas: mayor acceso a la información y a la prestación de servicios; fortalecimiento educativo; control de calidad de los programas de detección y reducción de los costos de la atención de en salud. Sin embargo, entre las principales barreras de adopción de la telemedicina se encuentran las de índole: tecnológicas; humanas y sociales; psicosociales y antropológicas; de Gobernanza y económicas. En estos 20 años se logró un aumento en los recursos y capacidad técnica, una mejora en la educación digital, un empoderamiento del paciente en su tratamiento y un mayor interés público en esta área. En especial se considera exitosa la conformación de equipos interdisciplinarios, las redes académicas y profesionales y las consultas médicas virtuales. Después de revisar el estado de la telemedicina en la Región de las Américas, los autores recomiendan adoptar medidas urgentes para poner en práctica políticas y programas nacionales de telemedicina, incluyendo el marco normativo y presupuesto necesario, cuya implementación se realice de manera integral e interoperable y que se sustente de redes académicas, de colaboración e instituciones especializadas. Dichas políticas deben generar un contexto habilitante que den sostenibilidad al avance logrado, considerando los aspectos mencionados en las posibles barreras.


[ABSTRACT]. With millions of people in the world in situations of physical distancing because of COVID-19, information and communication technology (ICT) has become as one of the principal means of interaction and collaboration. The following advantages of ICT have been cited since the start of the new millennium: increased access to information and service delivery, educational strengthening, quality control of screening programs, and reduction of health care costs. In the case of telemedicine, however, a number of barriers—especially technological, human and social, psychosocial, anthropological, economic, and governance-related—have stood in the way of its adoption. The past 20 years have seen an increase in the availability of resources and technical capacity, improvements in digital education, empowerment of patients regarding their treatment, and increased public interest in this area. Successes have included the use of interdisciplinary teams, academic and professional networking, and virtual medical consultations. After reviewing the state of telemedicine in the Region of the Americas, the authors recommend the urgent adoption of measures aimed at implementing national telemedicine policies and programs, including a regulatory framework and adequate funding. Implementation of the measures should be integrated and interoperable and include the support of academic networks and the collaboration of specialized institutions. The policies should generate an enabling context that ensures sustainability of the progress achieved, bearing in mind the possible barriers mentioned.


[RESUMO]. Com milhões de pessoas no mundo em situação de distanciamento físico devido à COVID-19, as tecnologias da informação e comunicação (TICs) se enquadraram como um dos meios principais de interação e colaboração. Já no início deste milênio, começaram a ser mencionadas as seguintes vantagens: maior acesso à informação e à prestação de serviços; fortalecimento da educação; controle de qualidade dos programas de detecção e redução dos custos na atenção à saúde. No entanto, entre as principais barreiras de adoção da telemedicina se encontram as de caráter: tecnológico; humano e social; psicossocial e antropológico; de governança e econômico. Nestes 20 anos, houve um aumento nos recursos e na capacidade técnica, uma melhora na educação digital, um empoderamento do paciente em seu tratamento e um maior interesse público nessa área. Em especial, são consideradas bem-sucedidas a constituição de equipes interdisciplinares e as redes acadêmicas e profissionais, e as consultas médicas virtuais. Após revisar o estado da telemedicina na Região das Américas, os autores recomendam a adoção de medidas urgentes para implementar políticas e programas nacionais de telemedicina, incluindo o marco normativo e o orçamento necessário. Essa implementação deve ser realizada de maneira integral e interoperável e sustentada por redes acadêmicas, de parceria e instituições especializadas. Tais políticas devem gerar um contexto favorável, dando sustentabilidade ao avanço obtido e considerando os aspectos mencionados nas possíveis barreiras.


Assuntos
Acesso à Informação , Desinformação , Prática de Saúde Pública , Saúde Pública , Planejamento em Saúde , Telemedicina , Acesso à Informação , Comunicação , Infodemia , Saúde Pública , Prática de Saúde Pública , Planejamento em Saúde , Telemedicina , Acesso à Informação , Desinformação , Saúde Pública , Prática de Saúde Pública , Planejamento em Saúde , COVID-19
15.
J Med Internet Res ; 2021 May 31.
Artigo em Inglês | MEDLINE | ID: mdl-34097638

RESUMO

BACKGROUND: During lockdown due to the COVID-19 pandemic, telemedicine has become a necessary component of clinical practice for the purpose of providing safer patient care, and it has been used to support the healthcare needs of COVID-19 patients and routine primary care patients alike. However, this change has not been fully consolidated. OBJECTIVE: The objective of this study was to analyse the determinants of healthcare professionals' intention to use the eConsulta digital clinical consultations tool in the post-COVID-19 context. METHODS: A literature review of the Technology Acceptance Model (TAM) allowed us to construct a theoretical model and establish a set of hypotheses derived from it about the influence that a variety of different factors relating to both healthcare professionals and the institutions where they work had on those professionals' intention to use eConsulta. In order to confirm the proposed model, a mixed qualitative and quantitative methodology was used, and a questionnaire was designed to serve as the data collection instrument. The data were analysed using univariate and bivariate analysis techniques. To confirm the theoretical model, exploratory factor analysis and binary logistic regression were applied. RESULTS: The most important variables were those referring to perceived benefits (B=2.408) and the type of use that individuals habitually made of eConsulta (B=0.715). Environmental pressure (B=0.678), experience of technology (B=0.542), gender (B=0.639) and the degree of eConsulta implementation (B=0.266) were other variables influencing the intention to use the tool in the post-COVID-19 context. When replicating the previous analysis by professional group, experience of technology and gender in the physician group, and experience of the tool's use and the centre where a professional works in the nurse group, were found to be of considerable importance. CONCLUSIONS: The implementation and use of eConsulta had increased significantly as a consequence of the COVID-19 pandemic, and the majority of the healthcare professionals were satisfied with its use in practice and planned to incorporate it into their practices in the post-COVID-19 context. Perceived benefits and environmental pressure were determining factors in the attitude towards and intention to use eConsulta.

16.
J Med Internet Res ; 23(5): e28629, 2021 05 27.
Artigo em Inglês | MEDLINE | ID: mdl-33970867

RESUMO

BACKGROUND: eConsulta-that is, asynchronous, two-way teleconsultation in primary care-is one of the most important telemedicine developments in the Catalan public health system, a service that has been heavily boosted by the onset of the COVID-19 pandemic. It is vital to know the characteristics of its users in order to be able to meet their needs and understand the coverage of this service in a context where there is reduced accessibility to the health system. OBJECTIVE: This study aims to analyze the profile of the citizens who use the eConsulta tool and the reasons for their use, as well as to gain an understanding of the elements that characterize their decision to use it while distinguishing between those who used it before and those who have used it since the onset of the COVID-19 pandemic. METHODS: A descriptive, observational study based on administrative data was performed. This study differentiates between the COVID-19 pandemic era and the period preceding it, considering the day the state of emergency was declared in Spain (ie, March 12, 2020) as the cut-off point. It also differentiates between eConsulta users who send messages and those who only receive them. RESULTS: During the pandemic, the number of unique users of this teleconsultation service had almost tripled, with up to 33.10 visits per 1000 inhabitants per month reported in the first three months. For the two user profiles analyzed, most users since the start of the COVID-19 outbreak were predominantly female, systematically younger, more actively employed, and with less complex pathologies. Furthermore, eConsulta users received more messages proactively from the health professionals. There was also a relative decrease in the number of conversations initiated by higher-income urban users and an increase in conversations initiated by users in rural areas. CONCLUSIONS: The COVID-19 pandemic has helped to generalize the use of telemedicine as a tool to compensate, to some extent, for the decline in face-to-face visits, especially among younger citizens in Catalonia. Telemedicine has made it possible to maintain contact between citizens and the health care system in the context of maximum complexity.


Assuntos
COVID-19/epidemiologia , Pandemias , Atenção Primária à Saúde , Saúde Pública , Consulta Remota , Adulto , Estudos Transversais , Atenção à Saúde , Surtos de Doenças , Feminino , Pessoal de Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Espanha/epidemiologia , Fatores de Tempo
17.
Artigo em Inglês | MEDLINE | ID: mdl-33920606

RESUMO

The lack of blood donors is a global problem that prevents the demand for blood prompted by an ageing population and increased life expectancy from being met. The aim of this study was to conduct an initial exploration of the reasons for using digital platforms in blood donation. Using a Theory of Planned Behaviour (TPB) framework, microdata for 389 participants from Latin American countries and Spain, and Partial Least Square-Structural Equation Modelling (PLS-SEM), the study obtained three main prediction paths. The first two started from feelings of trust in the digital community and a positive mood state associated with a modern lifestyle, and they were linked to attitudes and behavioural control in the explanation of the intention to donate and actual blood donation. The third path started from modern lifestyles, and was linked to the subjective norm in the prediction of intention and actual donation. These paths represent one of the very first attempts to predict intentions of donation and collaborative donation by taking a PLS-SEM approach. By determining the paths underpinning collaborative blood donors' motives, the results of this study provide strong support for the usefulness of the TPB model within the context of digital platform use and blood donation.


Assuntos
Doadores de Sangue , Motivação , Humanos , Intenção , América Latina , Espanha , Inquéritos e Questionários
18.
Artigo em Inglês | MEDLINE | ID: mdl-33925384

RESUMO

(1) Background: The aim of this study is to provide a better understanding of the requirements to improve routine health information systems (RHISs) for the management of health systems, including the identification of best practices, opportunities, and challenges in the 53 countries and territories of the WHO European region. (2) Methods: We conducted an overview of systematics reviews and searched the literature in the databases MEDLINE/PubMed, Cochrane, EMBASE, and Web of Science electronic databases. After a meticulous screening, we identified 20 that met the inclusion criteria, and RHIS evaluation results were presented according to the Performance of Routine Information System Management (PRISM) framework. (3) Results: The reviews were published between 2007 and 2020, focusing on the use of different systems or technologies and aimed to analyze interventions on professionals, centers, or patients' outcomes. All reviews examined showed variability in results in accordance with the variability of interventions and target populations. We have found different areas for improvement for RHISs according to the three determinants of the PRISM framework that influence the configuration of RHISs: technical, organizational, or behavioral elements. (4) Conclusions: RHIS interventions in the European region are promising. However, new global and international strategies and the development of tools and mechanisms should be promoted to highly integrate platforms among European countries.


Assuntos
Sistemas de Informação em Saúde , Humanos , Europa (Continente) , Gestão da Informação , Sistemas de Informação , Revisões Sistemáticas como Assunto
19.
Vaccines (Basel) ; 9(2)2021 Feb 18.
Artigo em Inglês | MEDLINE | ID: mdl-33670621

RESUMO

(1) Background: This study aims to delineate a pattern on vaccine hesitancy in a sample of the Spanish population, considering age groups and status as healthcare workers. (2) Methods: Participants were recruited using Twitter® as a dissemination tool to reach as many respondents as possible in different parts of the Spanish territory. The participants were recruited in a cross-sectional study, which included answering an online questionnaire. Data were collected from 10 September through 23 November 2020. Respondents answered questions asking whether they intended to be vaccinated and provided the main reason for their answers. To estimate associations between vaccination hesitancy and independent variables, we fit Poisson regression models with robust variance. (3) Results: One thousand and two responses were obtained, of which only 731 were validated. One hundred and sixty-four participants stated that they would not be vaccinated (22.43%), of which 20-24% were non-health workers or unemployed, 17.5% physicians, 31.5% other health workers, and almost 35% nurses. Concerns about lack of effectiveness of the vaccination, lack of safety when vaccinating and possibly dangerous adverse effects were the main causes provided. (4) Conclusions: This study indicates that more interventions are needed to achieve better communication with the population and health professionals. Receptiveness to the message of the importance and security of the COVID-19 vaccination could be an important strategy for improving these results.

20.
JMIR Res Protoc ; 10(2): e25062, 2021 Feb 03.
Artigo em Inglês | MEDLINE | ID: mdl-33533729

RESUMO

BACKGROUND: Due to the COVID-19 pandemic, it is more essential than ever to implement protective measures in primary care centers to ensure patients' safety. This protocol describes a quasiexperimental study on the use of a mobile chat platform as a clinical consultation tool for adolescents and primary health care physicians. OBJECTIVE: The purpose of the quasiexperimental study is to demonstrate that the use of mobile phones and messaging apps increases the number of health consultations. The study will be performed as part of the Health and School program in the Anoia region. METHODS: The quasiexperimental study will compare the number of face-to-face consultations to the number of consultations conducted on XatJove Anoia, as part of the Health in Schools program in the Anoia region. The study will involve the use of a new communication platform (ie, XatJove Anoia) for health care professionals and adolescents, and data on the number of face-to-face consultations will be collected as part of the same program in another region. Data will be collected from secondary schools during the academic year 2020-2021. Statistical analyses will be performed on the data that users will enter in the registration form. These data will be collected by means of a questionnaire, which will be submitted once the questionnaire is closed. The questionnaire will consist of multiple-choice questions, which will allow numerical values to be assigned to various responses in order to carry out statistical analyses. RESULTS: The study is projected to start at the beginning of November 2020 and finish in June 2021, which is when data analysis is expected to start. CONCLUSIONS: The results of the quasiexperimental study may assist in the development and planning of school health programs. TRIAL REGISTRATION: ClinicalTrials.gov NCT04562350; https://clinicaltrials.gov/ct2/show/NCT04562350. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/25062.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...